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It has been suggested that cancer stem cells (CSC) may play a central role in oncogenesis, especially in undifferentiated tumours.
Anaplastic thyroid carcinoma (ATC) has characteristics suggestive of a tumour enriched in CSC. Previous studies suggested that
the stem cell factor SOX2 has a preeminent hierarchical role in determining the characteristics of stem cells in SW1736 ATC cell
line. In detail, silencing SOX2 in SW1736 is able to suppress the expression of the stem markers analysed, strongly sensitizing the
line to treatment with chemotherapeutic agents. Therefore, in order to further investigate the role of SOX2 in ATC, a competing
endogenous RNA (ceRNA) analysis was conducted in order to isolate new functional partners of SOX2. Among the interactors,
of particular interest are genes involved in the biogenesis of miRNAs (DICER1, RNASEN, and EIF2C2), in the control cell cycle
(TP53, CCND1), and in mitochondrial activity (COX8A). The data suggest that stemness, microRNA biogenesis and functions, p53
regulatory network, cyclin D1, and cell cycle control, together with mitochondrial activity, might be coregulated.
1. Introduction
Anaplastic thyroid carcinoma (ATC) is a rare endocrine
tumour. Its morphological features resemble undifferentiated
neoplasm. Due to severe metastasis development and to the
rapid fatal course, surgery is rarely performed. Radiotherapy
and chemotherapy are also not very effective. It has been sug-
gested that those standard therapies are ineffective because
they are not able to efficiently target a subpopulation of ATC
cells, called the cancer-initiating cells or cancer stem cells
(CSCs). It has been proposed that CSCs possess stem-cell-like
features, are at the core of the development of many tumours,
especially undifferentiated ones like ATC, are responsible for
the recurrence of the tumour and metastasis formation, and
usually are very resistant to classical therapies.
Despitemany controversies regarding the cancer stem cell
model, it has the potential to drive the discovery of innovative
treatments that may eradicate the very chemoresistant core
of cancer [1]. In this connection, the CSC model is the sum
of many hypotheses that have arisen to explain the most
vexing aspects of cancer: metastasis, relapse, and therapeutic
resistance [2]. In this perspective, CSC research holds out
promise for improved treatment outcomes, in particular,
as regards overcoming resistance to chemotherapy on solid
tumours [1].
The most accepted CSC model makes use of a new
paradigm of cellular differentiation, in which cancer cells
can dedifferentiate toward more primitive, stem-like pheno-
types [2]. The dedifferentiation seems to be highly heteroge-
neous, giving an explanation to the observed discontinuous
behaviour of many cancers [2]. Alternatively, CSCs might
arise from transformed stem cells in the stem niche [1, 2].
Similar to normal stem cells, CSCs have the ability both to
self-renew and to give rise to differentiated tumour cells, are
responsible for the organization of a tumourmass [3], and are
tumorigenic when transplanted into an animal host [4]. CSCs
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Table 1: microRNAs that have been reported in the literature to regulate the main transcript from the SOX2 locus.
hsa-let-7a hsa-miR-125b-2∗ hsa-miR-1914∗ hsa-miR-30a∗
hsa-let-7a∗ hsa-miR-126 hsa-miR-1915 hsa-miR-30b
hsa-let-7b hsa-miR-126∗ hsa-miR-1915∗ hsa-miR-30b∗
hsa-let-7b∗ hsa-miR-134 hsa-miR-200c hsa-miR-30c
hsa-let-7c hsa-miR-137 hsa-miR-200c∗ hsa-miR-30c-1∗
hsa-let-7c∗ hsa-miR-142-3p hsa-miR-203 hsa-miR-30c-2∗
hsa-let-7d hsa-miR-143 hsa-miR-204 hsa-miR-30d
hsa-let-7d∗ hsa-miR-143∗ hsa-miR-205 hsa-miR-30d∗
hsa-let-7e hsa-miR-145 hsa-miR-206 hsa-miR-30e
hsa-let-7e∗ hsa-miR-145∗ hsa-miR-21 hsa-miR-30e∗
hsa-let-7f hsa-miR-155 hsa-miR-21∗ hsa-miR-452
hsa-let-7f-1∗ hsa-miR-155∗ hsa-miR-223 hsa-miR-452∗
hsa-let-7f-2∗ hsa-miR-17 hsa-miR-223∗ hsa-miR-9
hsa-let-7g hsa-miR-17∗ hsa-miR-296-3p hsa-miR-9∗
hsa-let-7g∗ hsa-miR-183 hsa-miR-296-5p hsa-miR-92a
hsa-let-7i hsa-miR-183∗ hsa-miR-302a hsa-miR-93
hsa-let-7i∗ hsa-miR-1908 hsa-miR-302a∗ hsa-miR-93∗
hsa-miR-100 hsa-miR-1909 hsa-miR-302b
hsa-miR-100∗ hsa-miR-1909∗ hsa-miR-302b∗
hsa-miR-106b hsa-miR-1910 hsa-miR-302c
hsa-miR-106b∗ hsa-miR-1911 hsa-miR-302c∗
hsa-miR-125a-3p hsa-miR-1911∗ hsa-miR-302d
hsa-miR-125a-5p hsa-miR-1912 hsa-miR-302d∗
hsa-miR-125b hsa-miR-1913 hsa-miR-302f
hsa-miR-125b-1∗ hsa-miR-1914 hsa-miR-30a
have been identified in awide range of human tumours [3]. At
the molecular level, CSCs are usually enriched in cell surface
markers such as CD44, CD24, and CD133, while Wnt/𝛽-
catenin, Notch, and Hedgehog signalling pathways seem to
have key roles in CSC properties [4]. Specific microRNA
signatures have been identified in many CSCs [4] that seem
to play a role in the epithelial-mesenchymal transition [4].
Regarding ATC, it has been hypothesized that the tumour
initiates from transformed thyroid stem cells, rather than
from differentiated thyrocytes undergoing a conventional
multistep carcinogenesis model [5–7].
The rarity and rapid fatal nature of ATC has led to
limited ex vivo studies. Here we describe an in vitro study
on a well-validated ATC cell line: SW1736. The SW1736 cell
line is characterized by a high percentage of population
with stem cell-like properties and high expression of several
stem markers (SOX2, OCT4, NANOG, C-MYC, SSEA4, and
the ABCG2 transporter) [8]. Interestingly, SOX2 silencing
downregulates in trans the expression of other stem cell
markers and sensitizes ATC cells to treatment with classical
chemotherapeutics such as cisplatin and doxorubicin [8].
This suggests that the stem cell factor SOX2 could have a pre-
eminent hierarchical role in determining the characteristics
of stem cells in SW1736 ATC cell line.
Therefore, in order to further investigate the role of SOX2
in ATC, a bioinformatic analysis of the functional network
of SOX2 was performed. In detail, a competing endogenous
RNA (ceRNA) analysis was conducted. This kind of analysis
is able to predict genes functionally correlated with the
bait gene rather than physically associated with it [9, 10].
The ceRNA hypothesis is based on the rationale that RNA
molecules can regulate one another via microRNAs [9, 10].
ceRNAs are RNAs that share miRNA recognition elements,
thereby regulating each other by influencing the available
level of miRNA [9, 10]. In the past, ceRNA analysis made
it possible to isolate several genes and functional networks
related to cancer development, ageing, and homeostasis [11–
19].
2. Materials and Methods
2.1. MirWALK Analysis. miRWalk is a comprehensive data-
base that provides information on miRNA from humans,
mice, and rats on their predicted as well as validated binding
sites on their target genes. The validated targets module
[20] hosts experimentally verified miRNA interaction with
associated genes.
Using the miRWalk [20] data and embedded tools, we
collected the microRNAs that have been reported in the
literature to regulate themain transcript from the SOX2 locus
(Table 1).
This set of miRNAs was inserted into the miRWalk
analysis tool [20] to collect any human mRNA that has been
reported to be regulated by them. Then the genes collected
were organized in a hierarchical order for the number of
validatedmicroRNA hits (Table 2).ThemoremicroRNAs are
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Table 2: ceRNA organized in hierarchical order for the number of
validated microRNA hits.
Gene Hits Gene Hits
DICER1 35 SLC27A4 10
TP53 26 RUNX1 10
RNASEN 22 RRBP1 10
EIF2C2 22 PAK3 10
COX8A 22 NFKB1 10
CCND1 22 LIN28 10
MYC 20 KLF4 10
CDKN1A 20 FRAP1 10
BCL2 20 EIF2C1 10
AKT1 19 CREB1 10
PTEN 18 CDK6 10
CDKN2A 18 APC 10
VEGFA 16 TWIST1 9
EGFR 16 SYNE1 9
TGFB1 14 SIRT1 9
KRAS 14 PRDM1 9
JUN 14 MCL1 9
HMGA2 14 HMOX1 9
ERBB2 14 DNMT1 9
ZEB1 13 DDX20 9
TLR4 13 CKAP4 9
SSSCA1 13 CDKN1C 9
MET 13 BRCA1 9
TNF 12 ZNF828 8
SOCS1 12 TP63 8
PIK3CA 12 TIMM8A 8
ESR1 12 STMN1 8
DGCR8 12 SCPEP1 8
CEBPB 12 ROS1 8
CD4 12 PSAT1 8
TGFBR2 11 PDCD4 8
STAT3 11 MYCN 8
PROM1 11 MAPK3 8
NPC1 11 JAK2 8
IL6 11 IL1B 8
EPHB2 11 IFNG 8
E2F3 11 IFNA1 8
E2F1 11 HMGA1 8
CDKN1B 11 GEMIN4 8
CTNNB1 8
CD19 8
BCL2L11 8
BAX 8
shared between the bait SOX2 gene and the candidate genes,
the higher the possibility that the candidate gene transcripts
can act as SOX2 ceRNAs. All analyses were updated to
December 15, 2013.
2.2. GeneMANIA Analysis. Arbitrarily, the top 6 genes
together with SOX2 were analysed using the GeneMANIA
[21] tool that helps to predict the functions of a set of genes
and to predict in which gene ontology (GO) functions the
set of genes might be involved (Figure 1) (Table 3). The GO
functions reported are the ones with a false discovery rate
(FDR) < 0.1. All analyses were updated to December 15, 2013.
2.3. Cell Cultures. The SW1736, 8505C, C643, FRO, BCPAP,
TPC-1, andWRO cell lines were cultured in Dulbecco’s mod-
ified Eagle’s medium high glucose medium supplemented
with 10% fetal bovine serum and 5% glutamine. Cultures were
maintained in 5% carbon dioxide at 37∘C in a humidified
incubator.
2.4. Small Interfering RNA (siRNA) Transfection. siRNA
transfection in SW1736 cells was performed using INTER-
FERin transfection agent (Polyplus-Transfection, Illkirch,
France), according to themanufacturer’s instructions. Briefly,
the transfection agent and the siRNA complex were added
to the cells and incubated for 72 hours for RNA extraction
and analysis. The final concentration of SOX2 siRNA was
100 nM. Each assay was performed in triplicate in at least
three independent experiments. SOX2 was silenced using
Stealth SiRNA SOX2 HSS144045 (Invitrogen, Milan, Italy).
siCONTROL Stealth siRNA Negative Control was used as a
control (Invitrogen, Milan).
2.5. SOX2 Coding Sequence Vector and Transient Transfection.
The vector used was taken from Addgen (http://www.add-
gene.org/) (Plasmid 26817): pcDNA3.3 SOX2; and trans-
formation into SW1736 cells was performed using Xfect
transfection agent (Clontech Laboratories, Inc. A Takara Bio
Company) according to the manufacturer’s instructions. The
transfection agent and plasmid were added to the cells and
incubated for 72 hours for RNA extraction and analysis.
2.6. SOX2 3󸀠 Untranslated Region (3󸀠UTR) Vector and
Transfection. The vector was synthesized in service by
Eurofins genomics (https://www.eurofinsgenomics.eu) using
a pcDNA 3.1 backbone and a chemically synthesized 3󸀠UTR
(as reported in http://mybioinfo.info/exon display.php?tax
id=9606&gene id=GeneID: 6657) (Table 4).
2.7. Reverse-Transcription PCR and Real-Time Quantitative
PCR. Total RNA was extracted from cells using the RNeasy
Mini Kit (Qiagen, Milan, Italy), including a digestion step
with DNase I. RNA quantity and quality were assessed using
the Nanodrop 2000 (Thermo Scientific, Wilmington, USA).
The RNA extracted was reverse-transcribed with Random
Hexamers (Applied Biosystems, Darmstadt, Germany) and
Improm II Reverse Transcriptase (Promega Italia, Milan,
Italy), according to the manufacturer’s protocol. Primer pair
sequences are reported in Table 5.
The reactions were performed as follows: 5󸀠 at 94∘C, 30
cycles (30󸀠󸀠 at 94∘C, 30󸀠󸀠 at 55∘C, 30󸀠󸀠 at 72∘C), 5󸀠 at 72∘C,
and stocked at 4∘C.The only exception was the amplification
of the SOX2 3󸀠UTR, for which the following was done: 5󸀠 at
94∘C, 30 cycles (30󸀠󸀠 at 94∘C, 30󸀠󸀠 at 55∘C, 90󸀠󸀠 at 72∘C), 5󸀠 at
72∘C, and stocked at 4∘C. Expression was analyzed by real-
time quantitative PCR (qRT-PCR) using Quantitect SYBR
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Figure 1: SOX2 ceRNA network by GeneMANIA.
Green PCR kit (Qiagen, Milan, Italy). All reactions were
performed using a Rotor-gene Q Instrument (Qiagen, Milan,
Italy). The data were analysed using the REST software [22].
2.8. Pool of Normal Thyroid Tissue. A pool of RNA from
normal thyroid tissue specimens was used, as described in
[23].
2.9. Limbal Stem Cell. A pool of RNA from limbal stem cells
specimens was used, as described in [24].
2.10. Lymphocytes. Peripheral blood samples of a healthy
volunteer were collected in tubes containing ethylenedi-
aminetetraacetic acid (EDTA, 1mg/mL) after 8 hours’ fasting.
Lymphocytes were isolated by lympholyte (CEDARLANE,
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Table 3: Gene ontology of SOX2 ceRNA network by GeneMANIA.
Function
False
discovery
rate
Coverage
Query genes n/a 7/7
Gene silencing by RNA 3.14𝑒 − 15 9/33
Gene silencing 5.01𝑒 − 13 9/59
Gene silencing by miRNA 1.3𝑒 − 11 7/25
Posttranscriptional gene silencing by
RNA 1.92𝑒 − 11 7/28
Posttranscriptional gene silencing 1.92𝑒 − 11 7/28
Regulation of gene expression, epigenetic 5.32𝑒 − 9 8/110
Production of miRNAs involved in gene
silencing by miRNA 1.24𝑒 − 8 5/13
dsRNA fragmentation 1.49𝑒 − 8 5/14
Production of small RNA involved in
gene silencing by RNA 1.49𝑒 − 8 5/14
Cellular response to dsRNA 7.77𝑒 − 8 5/19
Response to dsRNA 1.16𝑒 − 7 5/21
Respiratory electron transport chain 1.16𝑒 − 7 7/102
Electron transport chain 1.16𝑒 − 7 7/103
Cellular respiration 7.68𝑒 − 7 7/136
Mitochondrial membrane 3.2𝑒 − 6 8/274
ncRNA metabolic process 5.44𝑒 − 6 7/185
Mitochondrial envelope 5.44𝑒 − 6 8/297
Mitochondrial inner membrane 7.4𝑒 − 6 7/195
Organelle inner membrane 1.1𝑒 − 5 7/208
Posttranscriptional regulation of gene
expression 4.71𝑒 − 5 7/259
Energy derivation by oxidation of organic
compounds 7.46𝑒 − 5 7/279
Cellular response to organic cyclic
compound 2.23𝑒 − 4 5/101
ncRNA processing 2.59𝑒 − 4 5/105
Endonuclease activity, active with either
ribo- or deoxyribonucleic acids and
producing 5󸀠-phosphomonoesters
6.97𝑒 − 4 3/14
Endoribonuclease activity 1.25𝑒 − 3 3/17
Response to organic cyclic compound 3.56𝑒 − 3 5/183
Stem cell maintenance 1.09𝑒 − 2 3/35
Stem cell development 1.25𝑒 − 2 3/37
Ribonuclease activity 1.97𝑒 − 2 3/44
Endonuclease activity 1.97𝑒 − 2 3/44
Stem cell differentiation 4.17𝑒 − 2 3/57
Somatic stem cell maintenance 5.63𝑒 − 2 2/11
Germplasm 5.63𝑒 − 2 2/11
P granule 5.63𝑒 − 2 2/11
Pole plasm 5.63𝑒 − 2 2/11
Ribonucleoprotein granule 6.92𝑒 − 2 3/71
Endodermal cell fate commitment 7.54𝑒 − 2 2/13
Burlington, Ontario, Canada), according to the manufac-
turer’s instructions.
2.11. Statistical Analysis. We used the SPSS 13 software, Win-
dows edition, for all our statistical analyses. Correlationswere
determined using Spearman’s test (nonparametric equivalent
for Pearson’s test). 𝑃 < 0.05 was considered statistically
significant.
3. Results
Previous data [8] suggested that the stem cell factor SOX2
possesses a preeminent hierarchical role in determining
stemness characteristics in the SW1736 ATC cell line. With
the final aim of investigating the role of SOX2 in ATC,
a bioinformatic ceRNA analysis [9, 10] of the functional
network of SOX2 was performed.
Using the miRWalk [20] data and embedded tools, we
collected the microRNAs that have been reported in the
literature to regulate themain transcript from the SOX2 locus
(Table 1).
This set of miRNAs was inserted into the miRWalk
analysis tool [20] to collect any human mRNA that has been
reported to be regulated by them. Then the collected genes
were organized in a hierarchical order for the number of
validated microRNA hits (Table 2). The more microRNAs
are shared between SOX2 and the candidate genes, the
stronger the putative competitive effect that is at the core
of the ceRNA hypothesis. The first six top level interactors
were arbitrary selected for further analyses. The top level
SOX2 interactors in this ceRNA analysis areDICER1, EIF2C2,
and RNASEN, involved in miRNA biogenesis and functions
[25]; the most studied antioncogene TP53, worthy of note
because of its suggested role in stemness [26]; the nuclear-
coded mitochondrial Cytochrome C Oxidase Subunit VIIIA
COX8A [27]; and CCND1, the cyclin D coding gene [28].
Amongst the lesser interactors reported in Table 2, other
genes might be worth studying in the future, especially
for their involvement in oncogenesis (such as MYC, BCL2,
PTEN, KRAS, JUN, and many others).
This study aimed to analyse whether a relationship might
exist between the 6 top level interactors (DICER1, EIF2C2,
RNASEN, TP53, COX8A, and CCND1) and SOX2 in the ATC
cell line SW1736.
With this purpose in mind, the six interactors together
with SOX2 were analysed by GeneMANIA software [21]
to verify whether their putative network (Figure 1) might
be enriched in some GO annotations. Unsurprisingly, the
analysis revealed a statistically significant enrichment of
miRNA-mediated, posttranscriptional gene silencing activi-
ties (Table 3).
Then we tried to establish in the SW1736 ATC cell line
whether perturbations in the transcriptional state of SOX2
might alter in trans the transcriptional state of the ceRNAs
identified.Whenwe knocked down SOX2 transcripts via spe-
cific siRNA, all the ceRNAs were coherently downregulated
in trans in RT-PCR analyses, as expected. The effect of the
downregulation varied from one ceRNA to another but was
always statistically significant [22] (Figure 2(a)) (Table 6). To
further investigate whether the effect could be mediated by
the impaired transcriptional factor activity of the protein
coded by SOX2, we evaluated whether the overexpression of
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Table 4: SOX2 3󸀠 untranslated region (3󸀠UTR).
5󸀠GGGCCGGACAGCGAACTGGAGGGGGGAGAAATTTTCAAAGAAAAACGAGGGAAATGGGAGGGGTGCAAAA
GAGGAGAGTAAGAAACAGCATGGAGAAAACCCGGTACGCTCAAAAAGAAAAAGGAAAAAAAAAAATCCCATC
ACCCACAGCAAATGACAGCTGCAAAAGAGAACACCAATCCCATCCACACTCACGCAAAAACCGCGATGCCGAC
AAGAAAACTTTTATGAGAGAGATCCTGGACTTCTTTTTGGGGGACTATTTTTGTACAGAGAAAACCTGGGGA
GGGTGGGGAGGGCGGGGGAATGGACCTTGTATAGATCTGGAGGAAAGAAAGCTACGAAAAACTTTTTAAAAG
TTCTAGTGGTACGGTAGGAGCTTTGCAGGAAGTTTGCAAAAGTCTTTACCAATAATATTTAGAGCTAGTCTCC
AAGCGACGAAAAAAATGTTTTAATATTTGCAAGCAACTTTTGTACAGTATTTATCGAGATAAACATGGCAAT
CAAAATGTCCATTGTTTATAAGCTGAGAATTTGCCAATATTTTTCAAGGAGAGGCTTCTTGCTGAATTTTGA
TTCTGCAGCTGAAATTTAGGACAGTTGCAAACGTGAAAAGAAGAAAATTATTCAAATTTGGACATTTTAATT
GTTTAAAAATTGTACAAAAGGAAAAAATTAGAATAAGTACTGGCGAACCATCTCTGTGGTCTTGTTTAAAAA
GGGCAAAAGTTTTAGACTGTACTAAATTTTATAACTTACTGTTAAAAGCAAAAATGGCCATGCAGGTTGACA
CCGTTGGTAATTTATAATAGCTTTTGTTCGATCCCAACTTTCCATTTTGTTCAGATAAAAAAAACCATGAAAT
TACTGTGTTTGAAATATTTTCTTATGGTTTGTAATATTTCTGTAAATTTATTGTGATATTTTAAGGTTTTCCC
CCCTTTATTTTCCGTAGTTGTATTTTAAAAGATTCGGCTCTGTATTATTTGAATCAGTCTGCCGAGAATCCAT
GTATATATTTGAACTAATATCATCCTTATAACAGGTACATTTTCAACTTAAGTTTTTACTCCATTATGCACAG
TTTGAGATAAATAAATTTTTGAAATATGGACACTGAAA3󸀠
Table 5: RT-PCR primer pairs.
Gene Forward primer 5󸀠 > 3󸀠 Reverse primer 5󸀠 > 3󸀠
SOX2 CDS GGAGACGGAGCTGAAGCCGC GACGCGGTCCGGGCTGTTTT
DICER1 CTTTGCAACCCCTCAGCAT TCATGAATTGCTTCTTGTTGC
TP53 ATCTACTGGGACGGAACAGC GTGAGGCTCCCCTTTCTTG
RNASEN CACCGAGATCACAGTCATGG TGTCTTCTCCTGTCGGGACT
EIF2C2 TCCACCTAGACCCGACTTTG AACTCTCCTCGGGCACTTCT
COX8A TTACCTCCTGCTTCGTGACC CACTCTGGCCTCCTGTAGGT
CCND1 ATGCCAACCTCCTCAACG GGACCTCCTTCTGCACACAT
SOX2 3󸀠UTR CACCGGGCCGGACAGCGAACTGGAGGGGGG TTTCAGTGTCCATATTTCAAAAATTTATTTATC
𝛽-ACTIN GGACTTCGAGCAAGAGATGG AGCACTGTGTTGGCGTACAG
the coding sequence of SOX2 could have some in trans effects
on ceRNAs. The coding sequence lacks the 3󸀠 untranslated
region (3󸀠UTR) that mainly bears the regulation mediated by
miRNAs [29]. Our data indicate that no such effect occurs
(Figure 2(b)) (Table 7), so the trans effect highlighted in
(Figure 2(a)) is likely to be due to the endogenous miRNA
competition, as in our hypothesis, rather than a classical
interaction mediated by the proteic transcriptional factor
SOX2. Finally, we investigated whether the overexpression of
SOX2 3󸀠UTR might have any effects in trans in the SW1736
ATC cell line. The effects were very modest, if present at
all, but in line with the modulation that occurs during
the competing events [9, 10]. The most notable effect was
the positive correlation, as expected, with the expression of
EIF2C2 and SOX2 itself (Figure 2(c)) (Table 8).
The experiments previously described looked into the
effects of perturbation of the expression of SOX2 on the
expression of ceRNA genes in an ATC cell line. We then
endeavoured to see whether any correlation might exist
between the basal expression of SOX2 and the ceRNA genes
in different specimens. In detail, we analysed by RT-PCR the
relative expression of SOX2 and SOX2 ceRNAs compared
to 𝛽-ACTIN expression in SW1736 ATC cell line, in 8505C
ATC cell line, C643 ATC cell line, FRO ATC cell line,
BCPAP papillary thyroid carcinoma (PTC) cell line, TPC-
1 PTC cell line, WRO follicular thyroid carcinoma, and a
pool of normal thyroid tissues present in the laboratory
from previous experiments [23], a pool of limbal stem cells
[24], and isolated lymphocytes from a male donor of 36
years old (see Supplementary Table 1 in SupplementaryMate-
rial available online at http://dx.doi.org/10.1155/2014/439370).
Interestingly, this analysis suggested a correlation in the basal
expression ofDICER1,RNASEN, and EIF2C2 (Table 9), as can
be expected of genes whose functions are strictly coregulated
in the biogenesis and function ofmicroRNA, but surprisingly
their basal expression seemed also to be somehow related to
the basal expression of TP53 (Table 9), suggesting interesting
scenarios that will be discussed shortly.
4. Discussion
The ceRNA bioinformatics analysis pointed to a list of
genes that could be functionally coregulated with the stem
transcriptional factor SOX2 by a crosstalkmediated by several
miRNAs. In our analysis, we used interactions reported in the
literature instead of bioinformatically predicted ones as done
in the past [17–19].This approachmakes it possible to harvest
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Figure 2: Example of SOX2 and SOX2 ceRNAs levels of transcription quantified by RT-PCR compared to controls and normalized against
𝛽-actin expression in SW1736 ATC cell line. Whiskers represent the standard errors. (a) Analysis of SOX2 silencing. (b) Analysis of SOX2
coding sequence overexpression. (c) Analysis of SOX2 3󸀠UTR overexpression.
Table 6: Example of REST analysis on SOX2 and SOX2 ceRNAs levels of transcription quantified by RT-PCR compared to controls and
normalized against 𝛽-actin expression in SW1736 ATC cell line after SOX2 silencing. P(H1) is the probability of the alternative hypothesis
that the difference between sample and control groups is due only to chance.
Gene Reaction efficiency Expression Std. error 95% C.I. P(H1) Result
SOX2 0.6375 0.471 0.416–0.538 0.384–0.580 0.000 DOWN
DICER1 0.6125 0.442 0.373–0.523 0.366–0.533 0.000 DOWN
TP53 0.7025 0.394 0.364–0.427 0.348–0.445 0.170 DOWN
RNASEN 0.73 0.458 0.444–0.472 0.444–0.472 0.000 DOWN
EIF2C2 0.7475 0.355 0.326–0.386 0.320–0.394 0.000 DOWN
COX8A 0.69 0.635 0.572–0.705 0.560–0.720 0.000 DOWN
CCND1 0.6875 0.572 0.556–0.588 0.556–0.588 0.000 DOWN
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Table 7: Example of REST analysis on SOX2 and SOX2 ceRNAs levels of transcription quantified by RT-PCR compared to controls and
normalized against 𝛽-actin expression in SW1736 ATC cell line after SOX2 coding sequence (CDS) overexpression. P(H1) is the probability
of the alternative hypothesis that the difference between sample and control groups is due only to chance.
Gene Reaction efficiency Expression Std. error 95% C.I. P(H1) Result
SOX2 0.63 66.783 41.627–98.592 37.461–120.196 0.000 UP
DICER1 0.67 0.847 0.750–0.981 0.677–1.034 0.131
TP53 0.8175 1.099 1.000–1.198 0.953–1.261 0.136
RNASEN 0.7475 0.840 0.707–1.001 0.672–1.059 0.131
EIF2C2 0.7725 1.015 0.829–1.246 0.788–1.320 0.854
COX8A 0.765 1.430 1.197–1.699 1.136–1.788 0.000 UP
CCND1 0.755 0.861 0.763–0.947 0.721–1.056 0.080
Table 8: Example of REST analysis on SOX2 and SOX2 ceRNAs levels of transcription quantified by RT-PCR compared to controls and
normalized against 𝛽-actin expression in SW1736 ATC cell line after SOX2 3󸀠UTR overexpression. P(H1) is the probability of the alternative
hypothesis that the difference between sample and control groups is due only to chance.
Gene Reaction efficiency Expression Std. error 95% C.I. P(H1) Result
SOX2 0.655 1.414 1.176–1.710 1.102–1.818 0.000 UP
DICER1 0.7025 1.207 0.952–1.536 0.912–1.600 0.680
TP53 0.77 1.105 0.918–1.332 0.881–1.386 0.661
RNASEN 0.75 1.039 0.889–1.222 0.833–1.299 0.830
EIF2C2 0.765 1.508 1.393–1.641 1.314–1.733 0.169 UP
COX8A 0.785 0.879 0.733–1.068 0.669–1.160 0.680
CCND1 0.7425 1.226 1.045–1.462 0.937–1.611 0.341
SOX2 3󸀠UTR 0.64 3.092 2.577–3.762 2.330–4.119 0.000 UP
Table 9: Spearman two-tailed test correlations between basal gene expressions (as reported in Supplementary Table 1) among SW1736, 8505C,
C643, FRO, BCPAP, TPC-1, WRO, normal thyroid pool, limbal stem cells, and lymphocytes.
SOX2 DICER1 TP53 RNASEN EIF2C2 COX8A CCND1
SOX2
Rho 1 0.152 0.2 −0.176 0.042 0.321 −0.467
𝑃 0.676 0.580 0.627 0.907 0.365 0.174
DICER1
Rho 0.152 1 0.939 0.709 0.952 0.030 −0.067
𝑃 0.676 — <0.001 0.022 <0.001 0.934 0.855
TP53
Rho 0.200 0.939 1 0.770 0.939 −0.115 −0.042
𝑃 0.580 <0.001 — 0.009 <0.001 0.751 0.907
RNASEN
Rho −0.176 0.709 0.770 1 0.842 −0.382 0.261
𝑃 0.627 0.022 0.009 — 0.002 0.276 0.467
EIF2C2
Rho 0.042 0.952 0.939 0.842 1 −0.127 0.067
𝑃 0.907 <0.001 <0.001 0.002 — 0.726 0.855
COX8A
Rho 0.321 0.030 −0.115 −0.382 −0.127 1 −0.127
𝑃 0.365 0.934 0.751 0.276 0.726 — 0.726
CCND1
Rho −0.467 −0.067 −0.042 0.261 0.067 −0.127 1
𝑃 0.174 0.855 0.907 0.467 0.855 0.726 —
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more solid and reliable data, though it is easier to collect genes
that have been previously analysed.
Our experiments were pursued in an ATC cell line that
has previously been demonstrated to constitutively express
SOX2 that functionally possesses a preeminent hierarchical
role on many other stem cell factors [8], suggesting a leading
role in the maintenance of the stemness feature in this cell
line. ATC represents a very good candidate for a cancer
highly enriched in CSCs, which probably are at the core
of its unfavourable outcome [1–7]. For these reasons, it is
both important to understand the regulatory network that
underlies the functions of SOX2 in ATC, and at the same time
an ATC cell line is a very good candidate for studying the
SOX2 network.
Looking at the cross-regulation between SOX2 and the
most probable ceRNAs that we isolated, many if not all
the ceRNAs analysed seem to be responsive to alterations
in the transcriptional state of SOX2 transcripts, indepen-
dently of the coded protein, suggesting a regulatory network
strictly based on noncoding-RNAs (ncRNAs). The most
striking evidence is the effect of siRNA-mediated silencing on
SOX2, where all the ceRNAs are accordingly downregulated
(Figure 1(a)) (Table 6). By contrast, the overexpression of
the SOX2 CDS alone seems to have almost no effect at all
(Figure 1(b)) (Table 7). In contrast, the overexpression of the
3󸀠UTR of the SOX2 transcripts seems to have an upregulation
effect in trans, even if not to a great degree (Figure 1(c))
(Table 8). The 3󸀠UTR of transcripts is the portion of mes-
sengers that is likely to bear the vast majority of regulation
mediated by microRNAs [30]. The data reported here are
consistent with our hypothesis, so it is reasonable to point to
the ceRNAs isolated as potential functional interactors with
SOX2, at least in the SW1736 ATC cell line.
The interactors isolated pointed to a central role of
microRNA biogenesis and functions in SOX2 activities
(Table 3) and hence in stemness, as other authors have
recently suggested [29]. Here we report that probably the
transcription of SOX2 stem factors and of Dicer (DICER1),
Ago2 (EIF2C2), and Drosha (RNASEN) is coregulated by
a microRNA network. In detail, Drosha is a RNA-specific
endoribonuclease that is involved in the initial nuclear step
of microRNA biogenesis. Dicer is a cytoplasmic endori-
bonuclease that plays a central role in the production of
short interfering RNAs (siRNA) and mature microRNAs.
SiRNAs and microRNAs serve as a guide to directing the
RNA-induced silencing complex (RISC) to complementary
RNAs to degrade them or prevent their translation. Ago2
is the essential proteic core of the RISC complex. Overall,
the miRNA pathway is a means to specifically regulate the
expression of target genes that seem to directly and indirectly
affect tumorigenesis [31].
The SOX2 ceRNA TP53 gene codes for p53, one of the
most studied genes in relation to cancer development [32].
It is also often mutated in ATC towards a nonfunctional
form [33]. Nevertheless, even a mutated form, if transcribed,
can still exert its regulatory functions via its transcript (e.g.,
its 3󸀠UTR). In this perspective, homozygous deletion of the
locus or full silencing of the gene perturbs the network differ-
ently from a null mutation, which still permits transcription
from the locus. In the authors’ opinion, this distinction is
often not taken into account. It is interesting to note that some
authors have suggested a role of p53 in homoeostasis of the
stem niche [26] and in microRNA biogenesis [34], setting
it at a crossroads between cancer, stemness, and microRNA
biogenesis and functions. Our data are in support of this
interpretation, all themore so because the basal transcription
of TP53 seems to be correlated with the basal transcription
of DICER1, EIF2C2, and RNASEN in the specimens that we
analysed,many of them fromATC and other thyroid cell lines
(Table 9).
The SOX2 ceRNA CCND1 codes for cyclin D1, the regu-
latory subunit that promotes G1/S cell-cycle progression and
is involved in oncogenesis. It has been reported that cyclin
D1 induces Dicer expression in vitro and in vivo and vice
versa and their expression significantly correlates each other
(at least in some subtypes of human breast cancer). It has
been suggested that cyclin D1 induction of Dicer coordinates
microRNA biogenesis [28, 35]. Our data are in line with the
previous results and add a new level of possible crosstalk
between DICER1 and CCND1, suggesting novel actors in the
network previously isolated, such as SOX2 or TP53. It is likely
that cross-regulation between cyclin D1 and Dicer might
occur in other cancers, especially in ATC, which are enriched
in SOX2 producing cells [8], which we suggest is part of the
network.
The role of COX8A is more difficult to appraise. The
protein encoded by this gene is the terminal enzyme of the
respiratory chain that leads to the production of the electro-
chemical gradient across the innermitochondrialmembrane.
Recent discoveries suggest central roles of mitochondria in
the maintenance of pluripotency, differentiation, reprogram-
ming, and ageing [36]. Our data suggest possible crosstalk
between a crucial nuclear codedmitochondrial factor and cell
fate determinants such as SOX2 and TP53.
5. Conclusions
The SW1736 ATC cell line was used to investigate functional
SOX2 interactors isolated by a novel bioinformatics analysis.
Because SOX2 seems to have a central role in themaintenance
of stem features in the SW1736 ATC cell line, the interactors
are likely to play a role in stemness regulation.
The analysis pointed to DICER1, EIF2C2, RNASEN,
TP53, COX8A, and CCND1 genes, suggesting that stemness,
microRNAbiogenesis and functions, p53 regulatory network,
cyclin D1, and cell cycle control, together with mitochondrial
activity, might be coregulated as a whole in their functions.
Our data and previous data from the literature indicate that
those functions are strictly interlinked and that deregulation
of them might lead to cancer transformation, especially in
cancers such as ATC that possess an undifferentiated nature
suggestive of cancer stem cell enrichment.
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